VWA3A-derived ependyma promoter drives increased therapeutic protein secretion into the CSF is a research paper published in Molecular Therapy — Nucleic Acids (2023). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: NS111671
National Institutes of Health
Grant: P30 AGO62421-05
NIA NIH HHS
Grant: P30 AG062421
NINDS NIH HHS
Grant: U01 NS111671
National Institutes of Health
Grant: 1U01NS111671-01
Therapeutic APOE2 overexpression for early Alzheimer's disease
CHEO Research Institute
FWCI
2.00
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals